CNJ-016 Injection and Ibritumomab Intravenous
Determining the interaction of CNJ-016 Injection and Ibritumomab Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: vaccinia immune globulin
Brand name: Baciguent, Probiotic Formula, Proferrin-ES
Synonyms: n.a.
Generic Name: ibritumomab
Brand name: Y-90 Zevalin, In-111 Zevalin
Synonyms: Ibritumomab, Ibritumomab Tiuxetan
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- CNJ-016 Injection-Ibritumomab Tiuxetan
- CNJ-016 Injection-Ibrutinib
- CNJ-016 Injection-Ibrutinib Capsules
- CNJ-016 Injection-Ibrutinib Tablets
- CNJ-016 Injection-Ibu
- CNJ-016 Injection-IBU Tablets
- Ibritumomab Intravenous-Co-Gesic
- Ibritumomab Intravenous-Co-trimoxazole
- Ibritumomab Intravenous-Co-Veratrol
- Ibritumomab Intravenous-Coagadex
- Ibritumomab Intravenous-Coagulation factor IX
- Ibritumomab Intravenous-Coagulation factor ix recombinant Intravenous